Increase of nocturnal melatonin levels in hemodialyzed patients after parathyroidectomy - A pilot study

Physiological Research

Volumn 57, Issue SUPPL. 1, 2008, Pages

  Kancheva, R ^a   Sulkova S ^b   Svara F ^c   Hill, M ^a   Kanchev, L ^d   Zofkova I ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d NEW BULGARIAN UNIVERSITY   (Bulgaria)

Author keywords

Hemodialyzed patients; Hyperparathyroidism; Melatonin; Parathyroidectomy

Indexed keywords

CALCIUM; MELATONIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; FEMALE; HUMAN; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROIDECTOMY; PHYSIOLOGY; PILOT STUDY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CALCIUM; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; MALE; MELATONIN; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; PHOSPHATES; PILOT PROJECTS; RENAL DIALYSIS;

EID: 45849086101     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ABDEL-WANIS ME, KAWAHARA N, TOMITA K: The association of neurofibromatosis 1 and spinal deformity with primary hyperparathyroidism and osteomalacia: might melatonin have a role? J Orthop Sci 6: 193-198, 2001.
2. CHOU FF, LEE CH, CHEN JB, HUANG SC, LEE CT: Sleep disturbances before and after parathyroidectomy for secondary hyperparathyroidism. Surgery 137: 426-430, 2005.
3. FRASCHINI F, SCAGLIONE F, FRANCO P, DEMARTINI G, LUCINI V, STANKOV B: Melatonin and immunity. Acta Oncol 29: 775-776, 1990.
4. FRASER S, COWEN P, FRANKLIN M, FRANEY C, ARENDT J: Direct radioimmunoassay for melatonin in plasma. Clin Chem 29: 396-397, 1983.
5. ILLNEROVÁ H, SUMOVÁ A, TRÁVNÍČ KOVÁ Z, JÁČ M, JELÍNKOVÁ D: Hormones, subjective night and season of the year. Physiol Res 49 (Suppl 1): S1-S10, 2000.
6. KARASEK M, SZUFLET A, CHRZANOWSKI W, ZYLINSKA K, SWIETOSLAWSKI J: Circadian serum melatonin profiles in patients suffering from chronic renal failure. Neuroendocrinol Lett 23 (Suppl 1): 97-102, 2002.
7. KARASEK M, SZUFLET A, CHRZANOWSKI W, ZYLINSKA K, SWIETOSLAWSKI J: Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett 26: 653-656, 2005.
8. LUDEMANN P, ZWERNEMANN S, LERCHL A: Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease. J Pineal Res 31: 222-227, 2001.
9. MELOUN M, HILL M, MILITKÝ J, KUPKA K: Transformation in the PC-aided biochemical data analysis. Clin Chem Lab Med 38: 553-559, 2000.
10. MELOUN M, MILITKY J, HILL M, and BRERETON R G: Crucial problems in regression modelling and their solutions. Analyst 127: 433-450, 2002.
11. PHOCAS I, SARANDAKOU A, KASSANOS D, RIZOS D, TSERKEZIS G, KOUTSIKOS D: Hormonal and ultrasound characteristics of menstrual function during chronic hemodialysis and after successful renal transplantation. Int J Gynecol Obstet 37: 19-28, 1992.
12. SANGER DJ, SOUBRANE C, SCATTON B: New perspectives for the treatment of disorders of sleep and arousal. Ann Pharm Fr 65: 268-274, 2007.
13. WEISINGER JR, GONZALEZ L, ALVAREZ H, HERNANDEZ E, CARLINI RG, CAPRILES F, CERVINO M, MARTINIS R, PAZ-MARTINEZ V, BELLORIN-FONT E: Role of persistent amenorrhea in bone metabolism of young hemodialyzed women. Kidney Int 58: 331-335, 2000.
14. ZATZ M: Relationship between light, calcium influx and cAMP in the acute regulation of melatonin production by cultured chick pineal cells. Brain Res 477: 14-18, 1989.